JP2021503923A5

JP2021503923A5 -

Download PDF

Info

Publication number: JP2021503923A5
Authority: JP; Japan
Prior art keywords: item; days; hours; fibroblasts; cells
Prior art date: 2018-11-29
Legal status : Granted

Application number

JP2020529293A

Other languages

English (en)

Japanese (ja)

Other versions

JP7387603B2 (ja

JP2021503923A (ja

Filing date

2018-11-29

Publication date

2022-01-04

2018-11-29 Application filed filed Critical

2018-11-29 Priority claimed from PCT/US2018/063001 external-priority patent/WO2019108756A1/en

2021-02-15 Publication of JP2021503923A publication Critical patent/JP2021503923A/ja

2022-01-04 Publication of JP2021503923A5 publication Critical patent/JP2021503923A5/ja

2023-08-25 Priority to JP2023137037A priority Critical patent/JP2023159370A/ja

2023-11-28 Application granted granted Critical

2023-11-28 Publication of JP7387603B2 publication Critical patent/JP7387603B2/ja

Status Active legal-status Critical Current

2038-11-29 Anticipated expiration legal-status Critical

Links

238000000034 method Methods 0.000 claims description 267
210000002950 fibroblast Anatomy 0.000 claims description 104
210000004027 cell Anatomy 0.000 claims description 70
239000000203 mixture Substances 0.000 claims description 47
210000001616 monocyte Anatomy 0.000 claims description 44
210000002865 immune cell Anatomy 0.000 claims description 42
230000001363 autoimmune Effects 0.000 claims description 41
239000003795 chemical substances by application Substances 0.000 claims description 41
210000002966 serum Anatomy 0.000 claims description 28
239000002609 medium Substances 0.000 claims description 23
108010074328 Interferon-gamma Proteins 0.000 claims description 22
210000003289 regulatory T cell Anatomy 0.000 claims description 20
210000000130 stem cell Anatomy 0.000 claims description 20
102000004127 Cytokines Human genes 0.000 claims description 19
108090000695 Cytokines Proteins 0.000 claims description 19
241000282414 Homo sapiens Species 0.000 claims description 19
102100037850 Interferon gamma Human genes 0.000 claims description 19
230000001939 inductive effect Effects 0.000 claims description 17
102000003814 Interleukin-10 Human genes 0.000 claims description 15
108090000174 Interleukin-10 Proteins 0.000 claims description 15
102000015696 Interleukins Human genes 0.000 claims description 14
108010063738 Interleukins Proteins 0.000 claims description 14
239000000427 antigen Substances 0.000 claims description 13
108091007433 antigens Proteins 0.000 claims description 13
102000036639 antigens Human genes 0.000 claims description 13
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 13
108090001007 Interleukin-8 Proteins 0.000 claims description 12
102000004890 Interleukin-8 Human genes 0.000 claims description 12
230000002491 angiogenic effect Effects 0.000 claims description 12
210000004443 dendritic cell Anatomy 0.000 claims description 12
238000004519 manufacturing process Methods 0.000 claims description 12
102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 11
108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 11
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 11
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 11
210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 11
108010065805 Interleukin-12 Proteins 0.000 claims description 10
102000013462 Interleukin-12 Human genes 0.000 claims description 10
108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 10
210000004700 fetal blood Anatomy 0.000 claims description 10
239000003102 growth factor Substances 0.000 claims description 10
102000003812 Interleukin-15 Human genes 0.000 claims description 9
108090000172 Interleukin-15 Proteins 0.000 claims description 9
102000017761 Interleukin-33 Human genes 0.000 claims description 9
108010067003 Interleukin-33 Proteins 0.000 claims description 9
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 8
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 8
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 8
108050003558 Interleukin-17 Proteins 0.000 claims description 8
102000013691 Interleukin-17 Human genes 0.000 claims description 8
108090001005 Interleukin-6 Proteins 0.000 claims description 8
102000004889 Interleukin-6 Human genes 0.000 claims description 8
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 8
230000000694 effects Effects 0.000 claims description 8
210000004623 platelet-rich plasma Anatomy 0.000 claims description 8
108010002586 Interleukin-7 Proteins 0.000 claims description 7
102000000704 Interleukin-7 Human genes 0.000 claims description 7
230000035755 proliferation Effects 0.000 claims description 7
230000012010 growth Effects 0.000 claims description 6
239000006166 lysate Substances 0.000 claims description 6
210000002540 macrophage Anatomy 0.000 claims description 6
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 5
102000003971 Fibroblast Growth Factor 1 Human genes 0.000 claims description 5
230000001965 increasing effect Effects 0.000 claims description 5
206010019663 Hepatic failure Diseases 0.000 claims description 4
239000000556 agonist Substances 0.000 claims description 4
208000007903 liver failure Diseases 0.000 claims description 4
231100000835 liver failure Toxicity 0.000 claims description 4
TXQAZWIBPGKHOX-UHFFFAOYSA-N 1H-indol-3-amine Chemical compound C1=CC=C2C(N)=CNC2=C1 TXQAZWIBPGKHOX-UHFFFAOYSA-N 0.000 claims description 3
102000003745 Hepatocyte Growth Factor Human genes 0.000 claims description 3
108090000100 Hepatocyte Growth Factor Proteins 0.000 claims description 3
239000007640 basal medium Substances 0.000 claims description 3
239000000835 fiber Substances 0.000 claims description 3
238000000338 in vitro Methods 0.000 claims description 3
230000004968 inflammatory condition Effects 0.000 claims description 3
101000998139 Homo sapiens Interleukin-32 Proteins 0.000 claims description 2
101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 claims description 2
102000014158 Interleukin-12 Subunit p40 Human genes 0.000 claims description 2
108010011429 Interleukin-12 Subunit p40 Proteins 0.000 claims description 2
102100033501 Interleukin-32 Human genes 0.000 claims description 2
102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 claims description 2
241000700605 Viruses Species 0.000 claims description 2
238000002659 cell therapy Methods 0.000 claims description 2
230000002708 enhancing effect Effects 0.000 claims description 2
239000001963 growth medium Substances 0.000 claims description 2
239000000710 homodimer Substances 0.000 claims description 2
230000005847 immunogenicity Effects 0.000 claims description 2
210000004698 lymphocyte Anatomy 0.000 claims description 2
102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 2
210000003969 blast cell Anatomy 0.000 claims 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 44
-1 I. -309 Proteins 0.000 description 40
210000002901 mesenchymal stem cell Anatomy 0.000 description 39
201000010099 disease Diseases 0.000 description 38
208000011580 syndromic disease Diseases 0.000 description 38
206010016654 Fibrosis Diseases 0.000 description 24
230000004761 fibrosis Effects 0.000 description 22
239000002955 immunomodulating agent Substances 0.000 description 20
229940121354 immunomodulator Drugs 0.000 description 20
206010047115 Vasculitis Diseases 0.000 description 16
210000001185 bone marrow Anatomy 0.000 description 15
101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 14
102100025304 Integrin beta-1 Human genes 0.000 description 14
108010002350 Interleukin-2 Proteins 0.000 description 14
102000000588 Interleukin-2 Human genes 0.000 description 14
210000001778 pluripotent stem cell Anatomy 0.000 description 14
239000006041 probiotic Substances 0.000 description 14
235000018291 probiotics Nutrition 0.000 description 14
208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 12
201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 12
230000002757 inflammatory effect Effects 0.000 description 12
239000002243 precursor Substances 0.000 description 12
102000004388 Interleukin-4 Human genes 0.000 description 11
108090000978 Interleukin-4 Proteins 0.000 description 11
210000001744 T-lymphocyte Anatomy 0.000 description 11
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 11
229960002930 sirolimus Drugs 0.000 description 11
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 11
210000005259 peripheral blood Anatomy 0.000 description 10
239000011886 peripheral blood Substances 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 10
102000004452 Arginase Human genes 0.000 description 9
108700024123 Arginases Proteins 0.000 description 9
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 9
210000004185 liver Anatomy 0.000 description 9
230000000306 recurrent effect Effects 0.000 description 9
230000008929 regeneration Effects 0.000 description 9
238000011069 regeneration method Methods 0.000 description 9
108010021064 CTLA-4 Antigen Proteins 0.000 description 8
229940045513 CTLA4 antagonist Drugs 0.000 description 8
102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 8
208000007465 Giant cell arteritis Diseases 0.000 description 8
230000002519 immonomodulatory effect Effects 0.000 description 8
102000004114 interleukin 20 Human genes 0.000 description 8
108090000681 interleukin 20 Proteins 0.000 description 8
239000003446 ligand Substances 0.000 description 8
201000000596 systemic lupus erythematosus Diseases 0.000 description 8
206010043207 temporal arteritis Diseases 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
102100022749 Aminopeptidase N Human genes 0.000 description 7
108010074708 B7-H1 Antigen Proteins 0.000 description 7
101000840545 Bacillus thuringiensis L-isoleucine-4-hydroxylase Proteins 0.000 description 7
102100037241 Endoglin Human genes 0.000 description 7
102000000802 Galectin 3 Human genes 0.000 description 7
108010001517 Galectin 3 Proteins 0.000 description 7
102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 7
108010024164 HLA-G Antigens Proteins 0.000 description 7
101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 7
101000881679 Homo sapiens Endoglin Proteins 0.000 description 7
101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 description 7
101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 description 7
101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 7
102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 description 7
102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 7
101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 7
102100037589 OX-2 membrane glycoprotein Human genes 0.000 description 7
102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 7
101001037255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Indoleamine 2,3-dioxygenase Proteins 0.000 description 7
102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 7
230000001684 chronic effect Effects 0.000 description 7
239000003112 inhibitor Substances 0.000 description 7
201000008383 nephritis Diseases 0.000 description 7
235000013406 prebiotics Nutrition 0.000 description 7
102100022464 5'-nucleotidase Human genes 0.000 description 6
208000008190 Agammaglobulinemia Diseases 0.000 description 6
208000030939 Chronic inflammatory demyelinating polyneuropathy Diseases 0.000 description 6
235000008733 Citrus aurantifolia Nutrition 0.000 description 6
206010018364 Glomerulonephritis Diseases 0.000 description 6
101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 6
101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 6
206010020983 Hypogammaglobulinaemia Diseases 0.000 description 6
206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 6
206010061218 Inflammation Diseases 0.000 description 6
102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 6
102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 6
208000003250 Mixed connective tissue disease Diseases 0.000 description 6
102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 6
206010029379 Neutrophilia Diseases 0.000 description 6
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
206010043561 Thrombocytopenic purpura Diseases 0.000 description 6
235000011941 Tilia x europaea Nutrition 0.000 description 6
208000025865 Ulcer Diseases 0.000 description 6
102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 6
229960003697 abatacept Drugs 0.000 description 6
210000000577 adipose tissue Anatomy 0.000 description 6
208000007502 anemia Diseases 0.000 description 6
201000005795 chronic inflammatory demyelinating polyneuritis Diseases 0.000 description 6
208000019425 cirrhosis of liver Diseases 0.000 description 6
238000003501 co-culture Methods 0.000 description 6
208000006454 hepatitis Diseases 0.000 description 6
231100000283 hepatitis Toxicity 0.000 description 6
230000004054 inflammatory process Effects 0.000 description 6
239000004571 lime Substances 0.000 description 6
230000000529 probiotic effect Effects 0.000 description 6
208000002574 reactive arthritis Diseases 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
230000037390 scarring Effects 0.000 description 6
231100000397 ulcer Toxicity 0.000 description 6
FJLGEFLZQAZZCD-MCBHFWOFSA-N (3R,5S)-fluvastatin Chemical compound C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 FJLGEFLZQAZZCD-MCBHFWOFSA-N 0.000 description 5
208000003343 Antiphospholipid Syndrome Diseases 0.000 description 5
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 5
XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 5
XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 5
101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 5
101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 5
102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 5
UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 5
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 5
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 5
102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 5
DGOHFTDNMSZWDQ-UHFFFAOYSA-N N#C[Au]C#N Chemical compound N#C[Au]C#N DGOHFTDNMSZWDQ-UHFFFAOYSA-N 0.000 description 5
TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 5
RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 5
229960004308 acetylcysteine Drugs 0.000 description 5
229960001138 acetylsalicylic acid Drugs 0.000 description 5
229960002964 adalimumab Drugs 0.000 description 5
239000003470 adrenal cortex hormone Substances 0.000 description 5
230000000735 allogeneic effect Effects 0.000 description 5
229960005370 atorvastatin Drugs 0.000 description 5
AUJRCFUBUPVWSZ-XTZHGVARSA-M auranofin Chemical compound CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O AUJRCFUBUPVWSZ-XTZHGVARSA-M 0.000 description 5
229960005207 auranofin Drugs 0.000 description 5
RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 5
230000003176 fibrotic effect Effects 0.000 description 5
229960003765 fluvastatin Drugs 0.000 description 5
239000008103 glucose Substances 0.000 description 5
108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 5
239000003550 marker Substances 0.000 description 5
229960000485 methotrexate Drugs 0.000 description 5
208000008795 neuromyelitis optica Diseases 0.000 description 5
201000001119 neuropathy Diseases 0.000 description 5
230000007823 neuropathy Effects 0.000 description 5
230000002093 peripheral effect Effects 0.000 description 5
229960002965 pravastatin Drugs 0.000 description 5
TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 5
230000008569 process Effects 0.000 description 5
229960002855 simvastatin Drugs 0.000 description 5
RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 5
NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 5
229960001940 sulfasalazine Drugs 0.000 description 5
NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 5
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 4
102100032912 CD44 antigen Human genes 0.000 description 4
102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 4
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
108010036949 Cyclosporine Proteins 0.000 description 4
HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 4
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 4
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 4
102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 4
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 4
101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 4
101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 description 4
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 4
101001078133 Homo sapiens Integrin alpha-2 Proteins 0.000 description 4
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 4
102100025305 Integrin alpha-2 Human genes 0.000 description 4
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
102000003729 Neprilysin Human genes 0.000 description 4
108090000028 Neprilysin Proteins 0.000 description 4
102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 4
201000004681 Psoriasis Diseases 0.000 description 4
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 4
108020004459 Small interfering RNA Proteins 0.000 description 4
239000000853 adhesive Substances 0.000 description 4
230000001070 adhesive effect Effects 0.000 description 4
206010003230 arteritis Diseases 0.000 description 4
230000005784 autoimmunity Effects 0.000 description 4
229960001265 ciclosporin Drugs 0.000 description 4
229930182912 cyclosporin Natural products 0.000 description 4
208000035475 disorder Diseases 0.000 description 4
210000001671 embryonic stem cell Anatomy 0.000 description 4
210000003979 eosinophil Anatomy 0.000 description 4
229960005167 everolimus Drugs 0.000 description 4
208000024908 graft versus host disease Diseases 0.000 description 4
239000008101 lactose Substances 0.000 description 4
108020004999 messenger RNA Proteins 0.000 description 4
239000003226 mitogen Substances 0.000 description 4
208000033808 peripheral neuropathy Diseases 0.000 description 4
210000002826 placenta Anatomy 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
230000001568 sexual effect Effects 0.000 description 4
238000010374 somatic cell nuclear transfer Methods 0.000 description 4
230000009885 systemic effect Effects 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
208000032194 Acute haemorrhagic leukoencephalitis Diseases 0.000 description 3
201000004384 Alopecia Diseases 0.000 description 3
206010003267 Arthritis reactive Diseases 0.000 description 3
208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 3
206010003827 Autoimmune hepatitis Diseases 0.000 description 3
206010071577 Autoimmune hyperlipidaemia Diseases 0.000 description 3
206010064539 Autoimmune myocarditis Diseases 0.000 description 3
206010069002 Autoimmune pancreatitis Diseases 0.000 description 3
208000022106 Autoimmune polyendocrinopathy type 2 Diseases 0.000 description 3
208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 3
208000033222 Biliary cirrhosis primary Diseases 0.000 description 3
102100036841 C-C motif chemokine 1 Human genes 0.000 description 3
108010084313 CD58 Antigens Proteins 0.000 description 3
208000031229 Cardiomyopathies Diseases 0.000 description 3
208000005024 Castleman disease Diseases 0.000 description 3
108010019670 Chimeric Antigen Receptors Proteins 0.000 description 3
241000251730 Chondrichthyes Species 0.000 description 3
206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 3
208000015943 Coeliac disease Diseases 0.000 description 3
208000010007 Cogan syndrome Diseases 0.000 description 3
206010009900 Colitis ulcerative Diseases 0.000 description 3
208000013586 Complex regional pain syndrome type 1 Diseases 0.000 description 3
206010010741 Conjunctivitis Diseases 0.000 description 3
206010011258 Coxsackie myocarditis Diseases 0.000 description 3
208000011231 Crohn disease Diseases 0.000 description 3
208000019707 Cryoglobulinemic vasculitis Diseases 0.000 description 3
201000003883 Cystic fibrosis Diseases 0.000 description 3
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
201000004624 Dermatitis Diseases 0.000 description 3
208000021866 Dressler syndrome Diseases 0.000 description 3
201000009273 Endometriosis Diseases 0.000 description 3
206010015150 Erythema Diseases 0.000 description 3
206010049466 Erythroblastosis Diseases 0.000 description 3
208000004332 Evans syndrome Diseases 0.000 description 3
206010016207 Familial Mediterranean fever Diseases 0.000 description 3
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 3
102100037362 Fibronectin Human genes 0.000 description 3
108010067306 Fibronectins Proteins 0.000 description 3
241000192125 Firmicutes Species 0.000 description 3
102100033945 Glycine receptor subunit alpha-1 Human genes 0.000 description 3
208000024869 Goodpasture syndrome Diseases 0.000 description 3
206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 3
208000003807 Graves Disease Diseases 0.000 description 3
208000015023 Graves' disease Diseases 0.000 description 3
102000006354 HLA-DR Antigens Human genes 0.000 description 3
108010058597 HLA-DR Antigens Proteins 0.000 description 3
208000001204 Hashimoto Disease Diseases 0.000 description 3
208000030836 Hashimoto thyroiditis Diseases 0.000 description 3
206010019263 Heart block congenital Diseases 0.000 description 3
208000018565 Hemochromatosis Diseases 0.000 description 3
206010062639 Herpes dermatitis Diseases 0.000 description 3
101000713104 Homo sapiens C-C motif chemokine 1 Proteins 0.000 description 3
101000996297 Homo sapiens Glycine receptor subunit alpha-1 Proteins 0.000 description 3
101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 description 3
101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 3
101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 3
101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 3
101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 3
101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 description 3
101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 description 3
206010021143 Hypoxia Diseases 0.000 description 3
201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 3
208000010159 IgA glomerulonephritis Diseases 0.000 description 3
206010021263 IgA nephropathy Diseases 0.000 description 3
208000021330 IgG4-related disease Diseases 0.000 description 3
208000014919 IgG4-related retroperitoneal fibrosis Diseases 0.000 description 3
208000031781 Immunoglobulin G4 related sclerosing disease Diseases 0.000 description 3
208000004187 Immunoglobulin G4-Related Disease Diseases 0.000 description 3
208000027601 Inner ear disease Diseases 0.000 description 3
102100032819 Integrin alpha-3 Human genes 0.000 description 3
102100032818 Integrin alpha-4 Human genes 0.000 description 3
102100025390 Integrin beta-2 Human genes 0.000 description 3
102100032999 Integrin beta-3 Human genes 0.000 description 3
108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 3
102000008070 Interferon-gamma Human genes 0.000 description 3
102100030703 Interleukin-22 Human genes 0.000 description 3
208000005615 Interstitial Cystitis Diseases 0.000 description 3
208000003456 Juvenile Arthritis Diseases 0.000 description 3
206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 3
241000186604 Lactobacillus reuteri Species 0.000 description 3
201000010743 Lambert-Eaton myasthenic syndrome Diseases 0.000 description 3
208000012309 Linear IgA disease Diseases 0.000 description 3
102000004895 Lipoproteins Human genes 0.000 description 3
108090001030 Lipoproteins Proteins 0.000 description 3
210000004322 M2 macrophage Anatomy 0.000 description 3
102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 3
208000027530 Meniere disease Diseases 0.000 description 3
206010028372 Muscular weakness Diseases 0.000 description 3
208000021908 Myocardial disease Diseases 0.000 description 3
206010028594 Myocardial fibrosis Diseases 0.000 description 3
206010030113 Oedema Diseases 0.000 description 3
206010030216 Oesophagitis Diseases 0.000 description 3
208000003435 Optic Neuritis Diseases 0.000 description 3
206010053869 POEMS syndrome Diseases 0.000 description 3
208000008223 Pemphigoid Gestationis Diseases 0.000 description 3
108010069381 Platelet Endothelial Cell Adhesion Molecule-1 Proteins 0.000 description 3
208000012654 Primary biliary cholangitis Diseases 0.000 description 3
206010036805 Progressive massive fibrosis Diseases 0.000 description 3
101710150336 Protein Rex Proteins 0.000 description 3
201000001263 Psoriatic Arthritis Diseases 0.000 description 3
208000036824 Psoriatic arthropathy Diseases 0.000 description 3
206010037549 Purpura Diseases 0.000 description 3
241001672981 Purpura Species 0.000 description 3
208000006311 Pyoderma Diseases 0.000 description 3
201000001947 Reflex Sympathetic Dystrophy Diseases 0.000 description 3
208000033464 Reiter syndrome Diseases 0.000 description 3
206010038979 Retroperitoneal fibrosis Diseases 0.000 description 3
208000025747 Rheumatic disease Diseases 0.000 description 3
108090000184 Selectins Proteins 0.000 description 3
102000003800 Selectins Human genes 0.000 description 3
201000002661 Spondylitis Diseases 0.000 description 3
206010072148 Stiff-Person syndrome Diseases 0.000 description 3
206010042276 Subacute endocarditis Diseases 0.000 description 3
206010042742 Sympathetic ophthalmia Diseases 0.000 description 3
108091008874 T cell receptors Proteins 0.000 description 3
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 3
101150052863 THY1 gene Proteins 0.000 description 3
108010017842 Telomerase Proteins 0.000 description 3
108010079274 Thrombomodulin Proteins 0.000 description 3
102100026966 Thrombomodulin Human genes 0.000 description 3
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 3
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 3
208000026928 Turner syndrome Diseases 0.000 description 3
201000006704 Ulcerative Colitis Diseases 0.000 description 3
208000025851 Undifferentiated connective tissue disease Diseases 0.000 description 3
208000017379 Undifferentiated connective tissue syndrome Diseases 0.000 description 3
108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 3
102000013127 Vimentin Human genes 0.000 description 3
108010065472 Vimentin Proteins 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
230000001476 alcoholic effect Effects 0.000 description 3
231100000360 alopecia Toxicity 0.000 description 3
210000004381 amniotic fluid Anatomy 0.000 description 3
206010002022 amyloidosis Diseases 0.000 description 3
230000033115 angiogenesis Effects 0.000 description 3
230000001746 atrial effect Effects 0.000 description 3
201000004339 autoimmune neuropathy Diseases 0.000 description 3
201000009780 autoimmune polyendocrine syndrome type 2 Diseases 0.000 description 3
208000010928 autoimmune thyroid disease Diseases 0.000 description 3
208000029407 autoimmune urticaria Diseases 0.000 description 3
230000003376 axonal effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
201000004559 cerebral degeneration Diseases 0.000 description 3
208000024376 chronic urticaria Diseases 0.000 description 3
201000004395 congenital heart block Diseases 0.000 description 3
230000008602 contraction Effects 0.000 description 3
201000003278 cryoglobulinemia Diseases 0.000 description 3
201000001981 dermatomyositis Diseases 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
206010014599 encephalitis Diseases 0.000 description 3
201000002491 encephalomyelitis Diseases 0.000 description 3
231100000321 erythema Toxicity 0.000 description 3
208000006881 esophagitis Diseases 0.000 description 3
230000001605 fetal effect Effects 0.000 description 3
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 3
208000007475 hemolytic anemia Diseases 0.000 description 3
210000003494 hepatocyte Anatomy 0.000 description 3
208000021760 high fever Diseases 0.000 description 3
230000002584 immunomodulator Effects 0.000 description 3
208000027866 inflammatory disease Diseases 0.000 description 3
229960003130 interferon gamma Drugs 0.000 description 3
108010074108 interleukin-21 Proteins 0.000 description 3
208000036971 interstitial lung disease 2 Diseases 0.000 description 3
229940001882 lactobacillus reuteri Drugs 0.000 description 3
210000003141 lower extremity Anatomy 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
206010063344 microscopic polyangiitis Diseases 0.000 description 3
210000005087 mononuclear cell Anatomy 0.000 description 3
208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 3
230000036473 myasthenia Effects 0.000 description 3
201000003631 narcolepsy Diseases 0.000 description 3
208000015122 neurodegenerative disease Diseases 0.000 description 3
230000000422 nocturnal effect Effects 0.000 description 3
208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 3
206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 3
230000002611 ovarian Effects 0.000 description 3
230000001314 paroxysmal effect Effects 0.000 description 3
230000000737 periodic effect Effects 0.000 description 3
208000005987 polymyositis Diseases 0.000 description 3
229960003387 progesterone Drugs 0.000 description 3
239000000186 progesterone Substances 0.000 description 3
AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 3
230000001850 reproductive effect Effects 0.000 description 3
230000003938 response to stress Effects 0.000 description 3
230000000552 rheumatic effect Effects 0.000 description 3
201000003068 rheumatic fever Diseases 0.000 description 3
206010039073 rheumatoid arthritis Diseases 0.000 description 3
229960004641 rituximab Drugs 0.000 description 3
201000000306 sarcoidosis Diseases 0.000 description 3
208000017520 skin disease Diseases 0.000 description 3
208000008467 subacute bacterial endocarditis Diseases 0.000 description 3
230000001256 tonic effect Effects 0.000 description 3
208000009174 transverse myelitis Diseases 0.000 description 3
230000002792 vascular Effects 0.000 description 3
210000005048 vimentin Anatomy 0.000 description 3
101150097308 ARD1 gene Proteins 0.000 description 2
102100038740 Activator of RNA decay Human genes 0.000 description 2
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 2
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 2
208000032671 Allergic granulomatous angiitis Diseases 0.000 description 2
102000009840 Angiopoietins Human genes 0.000 description 2
108010009906 Angiopoietins Proteins 0.000 description 2
210000002237 B-cell of pancreatic islet Anatomy 0.000 description 2
102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 2
102100024210 CD166 antigen Human genes 0.000 description 2
101150013553 CD40 gene Proteins 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
206010008685 Chondritis Diseases 0.000 description 2
208000006344 Churg-Strauss Syndrome Diseases 0.000 description 2
241000193403 Clostridium Species 0.000 description 2
206010011732 Cyst Diseases 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
241001509319 Desulfitobacterium Species 0.000 description 2
101100270214 Dictyostelium discoideum natA gene Proteins 0.000 description 2
208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 2
108010008165 Etanercept Proteins 0.000 description 2
229930091371 Fructose Natural products 0.000 description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
239000005715 Fructose Substances 0.000 description 2
108091006027 G proteins Proteins 0.000 description 2
102000030782 GTP binding Human genes 0.000 description 2
108091000058 GTP-Binding Proteins 0.000 description 2
101150106864 HR gene Proteins 0.000 description 2
101000980840 Homo sapiens CD166 antigen Proteins 0.000 description 2
101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 2
101000595198 Homo sapiens Podocalyxin Proteins 0.000 description 2
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 2
101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 2
108050009527 Hypoxia-inducible factor-1 alpha Proteins 0.000 description 2
102100022338 Integrin alpha-M Human genes 0.000 description 2
229940119178 Interleukin 1 receptor antagonist Drugs 0.000 description 2
102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 2
108010092694 L-Selectin Proteins 0.000 description 2
102100033467 L-selectin Human genes 0.000 description 2
102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 2
101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 2
102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 2
101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 2
208000021642 Muscular disease Diseases 0.000 description 2
208000009525 Myocarditis Diseases 0.000 description 2
201000009623 Myopathy Diseases 0.000 description 2
CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
102100036031 Podocalyxin Human genes 0.000 description 2
DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
208000037534 Progressive hemifacial atrophy Diseases 0.000 description 2
206010039509 Scab Diseases 0.000 description 2
206010039710 Scleroderma Diseases 0.000 description 2
208000034189 Sclerosis Diseases 0.000 description 2
241000519995 Stachys sylvatica Species 0.000 description 2
230000006052 T cell proliferation Effects 0.000 description 2
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 2
206010071574 Testicular autoimmunity Diseases 0.000 description 2
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 2
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
210000001691 amnion Anatomy 0.000 description 2
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
238000011882 arthroplasty Methods 0.000 description 2
206010071578 autoimmune retinopathy Diseases 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
210000001612 chondrocyte Anatomy 0.000 description 2
230000007882 cirrhosis Effects 0.000 description 2
238000012258 culturing Methods 0.000 description 2
208000031513 cyst Diseases 0.000 description 2
230000016396 cytokine production Effects 0.000 description 2
230000003013 cytotoxicity Effects 0.000 description 2
231100000135 cytotoxicity Toxicity 0.000 description 2
230000007547 defect Effects 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
230000003210 demyelinating effect Effects 0.000 description 2
XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
229960002986 dinoprostone Drugs 0.000 description 2
238000005538 encapsulation Methods 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
229960000403 etanercept Drugs 0.000 description 2
238000011124 ex vivo culture Methods 0.000 description 2
CKSJXOVLXUMMFF-UHFFFAOYSA-N exalamide Chemical compound CCCCCCOC1=CC=CC=C1C(N)=O CKSJXOVLXUMMFF-UHFFFAOYSA-N 0.000 description 2
229950010333 exalamide Drugs 0.000 description 2
208000002980 facial hemiatrophy Diseases 0.000 description 2
239000012530 fluid Substances 0.000 description 2
229930182830 galactose Natural products 0.000 description 2
230000001146 hypoxic effect Effects 0.000 description 2
230000004957 immunoregulator effect Effects 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
229960000598 infliximab Drugs 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
239000003407 interleukin 1 receptor blocking agent Substances 0.000 description 2
229940028885 interleukin-4 Drugs 0.000 description 2
210000004153 islets of langerhan Anatomy 0.000 description 2
229920006008 lipopolysaccharide Polymers 0.000 description 2
210000005228 liver tissue Anatomy 0.000 description 2
239000000463 material Substances 0.000 description 2
210000004877 mucosa Anatomy 0.000 description 2
230000002107 myocardial effect Effects 0.000 description 2
210000004165 myocardium Anatomy 0.000 description 2
230000001338 necrotic effect Effects 0.000 description 2
210000002569 neuron Anatomy 0.000 description 2
230000002981 neuropathic effect Effects 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical group 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
230000004044 response Effects 0.000 description 2
230000008458 response to injury Effects 0.000 description 2
230000035939 shock Effects 0.000 description 2
230000011664 signaling Effects 0.000 description 2
239000004055 small Interfering RNA Substances 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
210000001550 testis Anatomy 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
102000003390 tumor necrosis factor Human genes 0.000 description 2
TYALNJQZQRNQNQ-UHFFFAOYSA-N #alpha;2,6-sialyllactose Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OCC1C(O)C(O)C(O)C(OC2C(C(O)C(O)OC2CO)O)O1 TYALNJQZQRNQNQ-UHFFFAOYSA-N 0.000 description 1
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
KFEUJDWYNGMDBV-UHFFFAOYSA-N (N-Acetyl)-glucosamin-4-beta-galaktosid Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 KFEUJDWYNGMDBV-UHFFFAOYSA-N 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
229940062827 2'-fucosyllactose Drugs 0.000 description 1
AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 description 1
LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
102100023990 60S ribosomal protein L17 Human genes 0.000 description 1
102100028348 60S ribosomal protein L26 Human genes 0.000 description 1
ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
102000006267 AMP Deaminase Human genes 0.000 description 1
108700016228 AMP deaminases Proteins 0.000 description 1
241001420322 Acetanaerobacterium Species 0.000 description 1
241001495178 Acetivibrio Species 0.000 description 1
241000204396 Acetonema Species 0.000 description 1
241001147780 Alicyclobacillus Species 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
241000197729 Alkaliphilus Species 0.000 description 1
241000147157 Ammonifex Species 0.000 description 1
241001147782 Amphibacillus Species 0.000 description 1
241000079561 Anaerofustis Species 0.000 description 1
241000195580 Anaerosporobacter Species 0.000 description 1
241001227086 Anaerostipes Species 0.000 description 1
241001013579 Anaerotruncus Species 0.000 description 1
241001626813 Anoxybacillus Species 0.000 description 1
101710115233 Arylsulfatase D Proteins 0.000 description 1
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000606125 Bacteroides Species 0.000 description 1
108010081589 Becaplermin Proteins 0.000 description 1
102100025991 Betaine-homocysteine S-methyltransferase 1 Human genes 0.000 description 1
241001202853 Blautia Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241001148534 Brachyspira Species 0.000 description 1
241000555281 Brevibacillus Species 0.000 description 1
241000249959 Bulleidia Species 0.000 description 1
241001557932 Butyricicoccus Species 0.000 description 1
241000605902 Butyrivibrio Species 0.000 description 1
102100036302 C-C chemokine receptor type 6 Human genes 0.000 description 1
101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 description 1
102000049320 CD36 Human genes 0.000 description 1
108010045374 CD36 Antigens Proteins 0.000 description 1
102100025222 CD63 antigen Human genes 0.000 description 1
102100035793 CD83 antigen Human genes 0.000 description 1
102100037904 CD9 antigen Human genes 0.000 description 1
102100029761 Cadherin-5 Human genes 0.000 description 1
101100289995 Caenorhabditis elegans mac-1 gene Proteins 0.000 description 1
101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241001058118 Caldanaerobacter Species 0.000 description 1
241000178334 Caldicellulosiruptor Species 0.000 description 1
241000178972 Caloramator Species 0.000 description 1
241000282421 Canidae Species 0.000 description 1
241000620141 Carboxydothermus Species 0.000 description 1
102100025470 Carcinoembryonic antigen-related cell adhesion molecule 8 Human genes 0.000 description 1
241000946390 Catenibacterium Species 0.000 description 1
101710098119 Chaperonin GroEL 2 Proteins 0.000 description 1
241000498849 Chlamydiales Species 0.000 description 1
206010008609 Cholangitis sclerosing Diseases 0.000 description 1
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
241001430149 Clostridiaceae Species 0.000 description 1
241001112695 Clostridiales Species 0.000 description 1
241000047490 Cohnella Species 0.000 description 1
208000011038 Cold agglutinin disease Diseases 0.000 description 1
206010009868 Cold type haemolytic anaemia Diseases 0.000 description 1
241001464956 Collinsella Species 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
241001443882 Coprobacillus Species 0.000 description 1
241001464948 Coprococcus Species 0.000 description 1
241001445332 Coxiella <snail> Species 0.000 description 1
108050006400 Cyclin Proteins 0.000 description 1
GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
108020004414 DNA Proteins 0.000 description 1
241001143296 Deferribacteres <phylum> Species 0.000 description 1
108700036803 Deficiency of interleukin-1 receptor antagonist Proteins 0.000 description 1
102100033672 Deleted in azoospermia-like Human genes 0.000 description 1
208000016192 Demyelinating disease Diseases 0.000 description 1
206010012305 Demyelination Diseases 0.000 description 1
241001313301 Dendrosporobacter Species 0.000 description 1
241001338026 Desulfosporosinus Species 0.000 description 1
241000186541 Desulfotomaculum Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241001143779 Dorea Species 0.000 description 1
201000010374 Down Syndrome Diseases 0.000 description 1
102100037569 Dual specificity protein phosphatase 10 Human genes 0.000 description 1
101710096804 Dual specificity protein phosphatase 10 Proteins 0.000 description 1
101150013191 E gene Proteins 0.000 description 1
102100039247 ETS-related transcription factor Elf-4 Human genes 0.000 description 1
241001657509 Eggerthella Species 0.000 description 1
206010014961 Eosinophilic myocarditis Diseases 0.000 description 1
102000009024 Epidermal Growth Factor Human genes 0.000 description 1
241000186811 Erysipelothrix Species 0.000 description 1
241000609971 Erysipelotrichaceae Species 0.000 description 1
241001350695 Ethanoligenens Species 0.000 description 1
241000186394 Eubacterium Species 0.000 description 1
102100029777 Eukaryotic translation initiation factor 3 subunit M Human genes 0.000 description 1
241001608234 Faecalibacterium Species 0.000 description 1
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
108090000380 Fibroblast growth factor 5 Proteins 0.000 description 1
102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
208000001640 Fibromyalgia Diseases 0.000 description 1
241000178967 Filifactor Species 0.000 description 1
241000662772 Flavonifractor Species 0.000 description 1
241000204479 Flexistipes Species 0.000 description 1
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
241000011639 Fulvimonas Species 0.000 description 1
241000605909 Fusobacterium Species 0.000 description 1
102000004862 Gastrin releasing peptide Human genes 0.000 description 1
108090001053 Gastrin releasing peptide Proteins 0.000 description 1
241001185600 Gemmiger Species 0.000 description 1
241000626621 Geobacillus Species 0.000 description 1
241001464794 Gloeobacter Species 0.000 description 1
208000009329 Graft vs Host Disease Diseases 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
102000001398 Granzyme Human genes 0.000 description 1
108060005986 Granzyme Proteins 0.000 description 1
102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
108010075704 HLA-A Antigens Proteins 0.000 description 1
241000144305 Halobacteroides Species 0.000 description 1
108090001102 Hammerhead ribozyme Proteins 0.000 description 1
101710113864 Heat shock protein 90 Proteins 0.000 description 1
241000207155 Heliobacterium Species 0.000 description 1
241001628319 Heliophilum Species 0.000 description 1
241001326442 Heliorestis Species 0.000 description 1
208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
206010019668 Hepatic fibrosis Diseases 0.000 description 1
102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
241000862469 Holdemania Species 0.000 description 1
101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
101000933413 Homo sapiens Betaine-homocysteine S-methyltransferase 1 Proteins 0.000 description 1
101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 1
101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 1
101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 1
101000914320 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 8 Proteins 0.000 description 1
101000871280 Homo sapiens Deleted in azoospermia-like Proteins 0.000 description 1
101000813135 Homo sapiens ETS-related transcription factor Elf-4 Proteins 0.000 description 1
101001012700 Homo sapiens Eukaryotic translation initiation factor 3 subunit M Proteins 0.000 description 1
101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
101001112162 Homo sapiens Kinetochore protein NDC80 homolog Proteins 0.000 description 1
101000934372 Homo sapiens Macrosialin Proteins 0.000 description 1
101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
101000982000 Homo sapiens N-alpha-acetyltransferase 15, NatA auxiliary subunit Proteins 0.000 description 1
101001023712 Homo sapiens Nectin-3 Proteins 0.000 description 1
101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 1
101000804728 Homo sapiens Protein Wnt-2b Proteins 0.000 description 1
101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
101000661600 Homo sapiens Steryl-sulfatase Proteins 0.000 description 1
101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
241000339806 Hydrogenoanaerobacterium Species 0.000 description 1
108091058560 IL8 Proteins 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
102000002746 Inhibins Human genes 0.000 description 1
108010004250 Inhibins Proteins 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
102100023915 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
108090000177 Interleukin-11 Proteins 0.000 description 1
102000003815 Interleukin-11 Human genes 0.000 description 1
102000003816 Interleukin-13 Human genes 0.000 description 1
108090000176 Interleukin-13 Proteins 0.000 description 1
102000003810 Interleukin-18 Human genes 0.000 description 1
108090000171 Interleukin-18 Proteins 0.000 description 1
102100023890 Kinetochore protein NDC80 homolog Human genes 0.000 description 1
241000579722 Kocuria Species 0.000 description 1
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
241000122535 Lachnoanaerobaculum Species 0.000 description 1
241001233595 Lachnobacterium Species 0.000 description 1
241001134638 Lachnospira Species 0.000 description 1
241001112693 Lachnospiraceae Species 0.000 description 1
241000186660 Lactobacillus Species 0.000 description 1
241001309423 Lactonifactor Species 0.000 description 1
241000589902 Leptospira Species 0.000 description 1
241000605635 Lutispora Species 0.000 description 1
241000568397 Lysinibacillus Species 0.000 description 1
101150001441 MANBA gene Proteins 0.000 description 1
102100025136 Macrosialin Human genes 0.000 description 1
108010054377 Mannosidases Proteins 0.000 description 1
102000001696 Mannosidases Human genes 0.000 description 1
241001046559 Marvinbryantia Species 0.000 description 1
102000013013 Member 2 Subfamily G ATP Binding Cassette Transporter Human genes 0.000 description 1
108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
241001430197 Mollicutes Species 0.000 description 1
241000178985 Moorella Species 0.000 description 1
101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
101100257363 Mus musculus Sox2 gene Proteins 0.000 description 1
102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
102100032975 Myosin-1 Human genes 0.000 description 1
101710204036 Myosin-1 Proteins 0.000 description 1
108010056296 N-Terminal Acetyltransferases Proteins 0.000 description 1
KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 description 1
HESSGHHCXGBPAJ-UHFFFAOYSA-N N-acetyllactosamine Natural products CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 1
102100026781 N-alpha-acetyltransferase 15, NatA auxiliary subunit Human genes 0.000 description 1
108010057466 NF-kappa B Proteins 0.000 description 1
102000003945 NF-kappa B Human genes 0.000 description 1
102100035487 Nectin-3 Human genes 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
241000187654 Nocardia Species 0.000 description 1
241001072230 Oceanobacillus Species 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
241000203287 Orenia Species 0.000 description 1
241000843248 Oscillibacter Species 0.000 description 1
241000266824 Oscillospira Species 0.000 description 1
241000178984 Oxalophagus Species 0.000 description 1
241000178986 Oxobacter Species 0.000 description 1
108010035766 P-Selectin Proteins 0.000 description 1
102100023472 P-selectin Human genes 0.000 description 1
102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 1
241000179039 Paenibacillus Species 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
241001446614 Papillibacter Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241001559000 Pelospora Species 0.000 description 1
241001425545 Pelotomaculum Species 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 1
206010065159 Polychondritis Diseases 0.000 description 1
229920001100 Polydextrose Polymers 0.000 description 1
101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 1
101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
102100040120 Prominin-1 Human genes 0.000 description 1
241000169380 Propionispora Species 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
241000280572 Pseudoflavonifractor Species 0.000 description 1
101150046080 RPL26 gene Proteins 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
241001662542 Robinsoniella Species 0.000 description 1
241000605947 Roseburia Species 0.000 description 1
241000095588 Ruminococcaceae Species 0.000 description 1
241000192031 Ruminococcus Species 0.000 description 1
108010011005 STAT6 Transcription Factor Proteins 0.000 description 1
241000187792 Saccharomonospora Species 0.000 description 1
241000192023 Sarcina Species 0.000 description 1
102100038081 Signal transducer CD24 Human genes 0.000 description 1
102100023980 Signal transducer and activator of transcription 6 Human genes 0.000 description 1
241000549372 Solobacterium Species 0.000 description 1
241000168515 Sporobacter Species 0.000 description 1
241000605066 Sporohalobacter Species 0.000 description 1
241000204117 Sporolactobacillus Species 0.000 description 1
241000204388 Sporomusa Species 0.000 description 1
241000186547 Sporosarcina Species 0.000 description 1
241000969788 Sporotomaculum Species 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
241000272534 Struthio camelus Species 0.000 description 1
241001136694 Subdoligranulum Species 0.000 description 1
241000123710 Sutterella Species 0.000 description 1
241000207198 Symbiobacterium Species 0.000 description 1
241000498538 Syntrophobotulus Species 0.000 description 1
241001656784 Syntrophococcus Species 0.000 description 1
241000606017 Syntrophomonas Species 0.000 description 1
230000006044 T cell activation Effects 0.000 description 1
241000846120 Terribacillus Species 0.000 description 1
241000186339 Thermoanaerobacter Species 0.000 description 1
241001647802 Thermobifida Species 0.000 description 1
241000035670 Thermosinus Species 0.000 description 1
102100033142 Transcription factor 20 Human genes 0.000 description 1
101710119730 Transcription factor 20 Proteins 0.000 description 1
102400001320 Transforming growth factor alpha Human genes 0.000 description 1
101800004564 Transforming growth factor alpha Proteins 0.000 description 1
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
241001425419 Turicibacter Species 0.000 description 1
101150037984 UBE2D3 gene Proteins 0.000 description 1
102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 1
108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
229920000392 Zymosan Polymers 0.000 description 1
UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
TYALNJQZQRNQNQ-JLYOMPFMSA-N alpha-Neup5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)O[C@@H]2CO)O)O1 TYALNJQZQRNQNQ-JLYOMPFMSA-N 0.000 description 1
229940043215 aminolevulinate Drugs 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
229920000617 arabinoxylan Polymers 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
239000011324 bead Substances 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000002449 bone cell Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
108010018828 cadherin 5 Proteins 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
201000001352 cholecystitis Diseases 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
230000006378 damage Effects 0.000 description 1
210000004544 dc2 Anatomy 0.000 description 1
210000004489 deciduous teeth Anatomy 0.000 description 1
230000004041 dendritic cell maturation Effects 0.000 description 1
230000002357 endometrial effect Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000003953 foreskin Anatomy 0.000 description 1
210000004475 gamma-delta t lymphocyte Anatomy 0.000 description 1
208000018090 giant cell myocarditis Diseases 0.000 description 1
RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
210000004024 hepatic stellate cell Anatomy 0.000 description 1
102000054458 human STS Human genes 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
230000003259 immunoinhibitory effect Effects 0.000 description 1
230000006057 immunotolerant effect Effects 0.000 description 1
239000000893 inhibin Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000014828 interferon-gamma production Effects 0.000 description 1
208000028774 intestinal disease Diseases 0.000 description 1
230000000302 ischemic effect Effects 0.000 description 1
IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 description 1
229940062780 lacto-n-neotetraose Drugs 0.000 description 1
229940039696 lactobacillus Drugs 0.000 description 1
208000002741 leukoplakia Diseases 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000007799 mixed lymphocyte reaction assay Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
229940035032 monophosphoryl lipid a Drugs 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000000581 natural killer T-cell Anatomy 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000001776 parthenogenetic effect Effects 0.000 description 1
230000033064 perforin production Effects 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
210000005059 placental tissue Anatomy 0.000 description 1
239000001259 polydextrose Substances 0.000 description 1
229940035035 polydextrose Drugs 0.000 description 1
235000013856 polydextrose Nutrition 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
201000000742 primary sclerosing cholangitis Diseases 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000035752 proliferative phase Effects 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
230000009467 reduction Effects 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
210000004708 ribosome subunit Anatomy 0.000 description 1
208000010157 sclerosing cholangitis Diseases 0.000 description 1
230000028327 secretion Effects 0.000 description 1
210000000717 sertoli cell Anatomy 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
210000004500 stellate cell Anatomy 0.000 description 1
208000026082 sterile multifocal osteomyelitis with periostitis and pustulosis Diseases 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000008467 tissue growth Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1

JP2020529293A 2017-11-29 2018-11-29 活性化のための線維芽細胞と免疫細胞との相互作用及びそれらの使用 Active JP7387603B2 (ja)